Dennis Polk, who serves on TD Synnex's board of directors and holds the chair position at Hyve Solutions, sold 2,500 shares of the company's common stock on April 17, 2026. The shares were transacted at $210.7 each, producing gross proceeds of $526,750.
The sale was carried out under a pre-established Rule 10b5-1 trading arrangement. That plan was put in place by the Polk Family Trust on January 16, 2026; Polk acts as a trustee for the trust. Following the sale, Polk's reported holdings include 22,439 shares held directly and 81,647 shares held indirectly through the trust.
The timing of the disposition coincides with SNX trading levels close to the stock's 52-week high of $210.02. Over the past year, the shares have appreciated by approximately 100%.
Market commentary included an analysis from InvestingPro indicating the stock remains undervalued at current price levels. For investors seeking additional context on valuation and performance, InvestingPro is cited as offering access to comprehensive Pro Research Reports and more than 15 additional ProTips specific to this security.
Polk's transaction comes in the wake of TD Synnex's fiscal first-quarter 2026 results, which outperformed consensus estimates. The company reported earnings per share of $4.73 versus an expected $3.32, representing a 42.47% positive surprise. Revenue for the quarter reached $17.16 billion, above the anticipated $15.59 billion, a variance reported as a 10.07% increase versus expectations.
Following the earnings release, sell-side analysts adjusted their outlooks. RBC Capital raised its price target from $180 to $210 while maintaining an Outperform rating. Raymond James lifted its price target from $175 to $200, citing strong growth in revenue and profitability measures; that brokerage also noted earnings per share expanded by nearly 70% during the quarter.
These analyst moves and the company's reported financials were cited as indicators of investor confidence in TD Synnex's revenue growth and profitability trends. The director sale was conducted through the pre-arranged plan and was disclosed alongside the broader market context of rising share prices and upward revisions from equity analysts.
Contextual note - The sale was executed under a Rule 10b5-1 plan adopted on January 16, 2026 by the Polk Family Trust, for which Polk serves as trustee. Polk continues to hold both direct and indirect positions in the company following the sale.